Inhaled iloprost as third add-on therapy in idiopathic pulmonary arterial hypertension

被引：6
|
作者：
Fernandes, Caio J. C. S. [1 ,2 ,3 ]
da Silva, Taysa A. F. [1 ]
Alves Jr, Jose L. [1 ,2 ,3 ]
Jardim, Carlos V. P. [1 ,3 ]
de Souza, Rogerio [1 ,3 ]
机构：
[1] Univ Sao Paulo, Heart Inst, Med Sch, Pulm Circulat Unity,Cardiopulmonol Dept, 44 Dr Eneas Carvalho Aguiar Av, BR-05403000 Sao Paulo, SP, Brazil
[2] Univ Sao Paulo, Med Sch, Canc Inst, Sao Paulo, Brazil
[3] Sirio Libanes Hosp, Sao Paulo, Brazil
来源：
PULMONARY CIRCULATION | 2021年 / 11卷 / 01期
关键词：
inhaled iloprost; sequential triple combination therapy; pulmonary arterial hypertension; hemodynamics; COMBINATION THERAPY; REGISTRY;
D O I：
10.1177/2045894020981350
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Triple combination therapy is suggested in current pulmonary arterial hypertension guidelines in case of unsatisfactory treatment with oral double combination therapy. However, there is a lack of evidence concerning some of the drug combinations currently employed. We demonstrate the clinical and hemodynamical benefits of inhaled iloprost as third add-on therapy in idiopathic pulmonary arterial hypertension.
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Inhaled iloprost for severe pulmonary hypertension
    Olschewski, H
    Simonneau, G
    Galiè, N
    Higenbottam, T
    Naeije, R
    Rubin, LJ
    Nikkho, S
    Speich, R
    Hoeper, MM
    Behr, J
    Winkler, J
    Sitbon, O
    Popov, W
    Ghofrani, HA
    Manes, A
    Kiely, DG
    Ewert, R
    Siedentop, H
    Seeger, W
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (05): : 322 - 329
  • [32] Inhaled iloprost - In primary pulmonary hypertension
    Goldsmith, DR
    Wagstaff, AJ
    [J]. DRUGS, 2004, 64 (07) : 763 - 773
  • [33] Transition from IV Epoprostenol to Oral/Inhaled Targeted Pulmonary Arterial Hypertension Therapy In Pediatric Idiopathic Pulmonary Arterial Hypertension
    Melnick, L. E.
    Barst, R. J.
    Rowan, C. A.
    Kerstein, Diane
    Brady, D.
    Rosenzweig, E. B.
    [J]. CIRCULATION, 2008, 118 (18) : S877 - S877
  • [34] Oral sildenafil as long-term adjunct therapy to inhaled iloprost in severe pulmonary arterial hypertension
    Ghofrani, HA
    Rose, F
    Schermuly, RT
    Olschewski, H
    Wiedemann, R
    Kreckel, A
    Weissmann, N
    Ghofrani, S
    Enke, B
    Seeger, W
    Grimminger, F
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 42 (01) : 158 - 164
  • [35] Short- and long-term effects of inhaled iloprost therapy in children with pulmonary arterial hypertension
    Ivy, D. Dunbar
    Doran, Aimee K.
    Smith, Kelly J.
    Mallory, George B.
    Beghetti, Maurice
    Barst, Robyn J.
    Brady, Danicla
    Law, Yuk
    Parker, Donna
    Claussen, Lori
    Abman, Steven H.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (02) : 161 - 169
  • [36] Safety and efficacy of immunoadsorption as an add-on to medical treatment in patients with severe idiopathic pulmonary arterial hypertension (IPAH)
    Egenlauf, B.
    Nagel, C.
    Ewert, R.
    Lehmkuhl, H.
    Rosenkranz, S.
    Benjamin, N.
    Schwenger, V.
    Herth, F.
    Gruenig, E.
    [J]. EUROPEAN HEART JOURNAL, 2018, 39 : 320 - 320
  • [37] Acute effects of inhaled iloprost on intracardiac conduction in patients with pulmonary arterial hypertension
    Yildiz, Mustafa
    Kahraman, Serkan
    Surgit, Ozgur
    Agus, Hicaz Zencirkiran
    Uygur, Begum
    Demir, Ali R.
    Kalkan, Mehmet E.
    Sancar, Kadriye Memic
    Oner, Ender
    Gurbak, Ismail
    Kalkan, Ali K.
    [J]. HERZ, 2022, 47 (02) : 158 - 165
  • [38] Randomized study of adding inhaled iloprost to existing bosentan in pulmonary arterial hypertension
    McLaughlin, Vallerie V.
    Oucliz, Ronald J.
    Frost, Aclaani
    Tapson, Victor F.
    Murali, Srinivas
    Channick, Richard N.
    Badesch, David B.
    Barst, Robyn J.
    Hsu, Henry H.
    Rubin, Lewis J.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2006, 174 (11) : 1257 - 1263
  • [39] Long-term inhaled iloprost use in children with pulmonary arterial hypertension
    Alehan, Dursun
    Yildirim, Isil
    Sahin, Murat
    Ozkutlu, Suheyla
    Ozer, Sema
    Karagoz, Tevfik
    [J]. CARDIOLOGY IN THE YOUNG, 2012, 22 (04) : 396 - 403
  • [40] Switching inhaled iloprost formulations in patients with pulmonary arterial hypertension: the VENTASWITCH Trial
    Richter, Manuel J.
    Stollfuss, Barbara
    Roitenberg, Alexander
    Kleinjung, Frank
    Graeff, Valentin
    Berghaus, Sabine
    Mueller, Christian
    Ghofrani, Hossein-Ardeschir
    [J]. PULMONARY CIRCULATION, 2018, 8 (04)
12345